Live Breaking News & Updates on Dong seung seen

GPCR Therapeutics Announces Out-Licensing Agreement with Bridge Biotherapeutics in Idiopathic Pulmonary Fibrosis

GPCR Therapeutics Announces Out-Licensing Agreement with Bridge Biotherapeutics in Idiopathic Pulmonary Fibrosis
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

London , City-of , United-kingdom , United-states , Seoul , Soult-ukpyolsi , South-korea , American , Republic-of-korea , Daniel-gooch , Dayoon-kim , James-lee

GPCR Therapeutics Announces Publication on Improving Hematopoietic Stem Cell Mobilization Using Propranolol with GPC-100

GPCR Therapeutics Announces Publication on Improving Hematopoietic Stem Cell Mobilization Using Propranolol with GPC-100
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Seoul , Soult-ukpyolsi , South-korea , Dayoon-kim , Therapeutics-inc , Institute-of-microbiology , Business-development-managertel , Linkedin , Seoul-national-university , Seoul-national-university-school-of-biological-sciences , Biological-sciences

GPCR Therapeutics Demonstrates Clinical Improvement in Mobilization of Hematopoietic Stem Cells Using GPC-100/Burixafor in Clinical Pharmacology in Drug Development

GPCR Therapeutics, Inc., a clinical stage, international biopharmaceutical company with an innovative approach to drug discovery based on targeting G Protein Coupled Receptors (GPCR) pairs, announced today publication of their paper in Clinical Pharmacology in Drug Development (1), in collaboration with Taiwan’s ...

United-states , Seoul , Soult-ukpyolsi , South-korea , California , Redwood-city , Therapeutics-inc , Taiwan-taigen-biotechnology-co , Clinical-pharmacology-in-drug-development , Clinical-pharmacology , Drug-development

GPCR passes Technology Evaluation process for listing on KOSDAQ

GPCR passes Technology Evaluation process for listing on KOSDAQ

South-korea , United-states , Seoul , Soult-ukpyolsi , Australia , Taiwan , Korea , Korea-exchange , Linkedin , Technology-evaluation , Therapeutics-inc

GPCR Therapeutics Announces Launch of US Phase 2 Trial of GPC-100 in Multiple Myeloma

GPCR Therapeutics, Inc., a venture-backed, clinical stage, international biopharmaceutical company with an innovative approach to drug discovery based on targeting G Protein Coupled Receptors (GPCR) pairs, announced today the initiation of their phase 2 trial in the US for its lead small molecule asset, GPC-100 ...

Seoul , Soult-ukpyolsi , South-korea , California , United-states , Redwood-city , Pina-cardarelli , Omar-nadeem , Muthalagu-ramanathan , Therapeutics-inc , University-of-massachusetts-chan-medical-school , Dana-farber-cancer-institute